(Total Views: 521)
Posted On: 02/05/2023 8:05:18 PM
Post# of 154851
I am a little ambivalent too; you google Leronlimab, you the FDA hit letter, google CytoDyn, you get the hold and investigations.
On the other hand I like the name Leronlimab and the name CytoDyn and if the Amarex situation turns out to be a BP corruption, then keeping those names could be good for us.
On the other hand I like the name Leronlimab and the name CytoDyn and if the Amarex situation turns out to be a BP corruption, then keeping those names could be good for us.
(1)
(0)
